Skip to main content
SpringerLink
Log in

Myocardial stunning following defibrillation threshold testing

  • CASE REPORT
  • Published:
Journal of Interventional Cardiac Electrophysiology Aims and scope Submit manuscript

Abstract

Implantable cardioverter-defibrillators (ICDs) have a proven mortality benefit in appropriately selected people. Several retrospective studies, though, have postulated that appropriate ICD therapy may lead to fatal, pulseless electrical alternans (PEA). This case report describes an episode of transient PEA from myocardial stunning and standstill following defibrillation threshold testing. The risk of post-shock myocardial stunning and standstill should be kept in mind as a potential complication of testing. With rapid recognition and prompt intervention, this complication is potentially reversible.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Pires, L. A., Lehmann, M. H., Steinman, R. T., Baga, J. J., & Schuger, C. D. (1999). Sudden death in implantable cardioverter-defibrillator recipients: Clinical context, arrhythmic events and device responses. Journal of the American College of Cardiology, 33, 24–32.

    Article  PubMed  CAS  Google Scholar 

  2. Mitchell, L. B., Pineda, E. A., Titus, J. L., & Bartosch, P. M. (2002). Sudden death in patients with implantable cardioverter defibrillators. Journal of the American College of Cardiology, 39, 1323–1328.

    Article  PubMed  Google Scholar 

  3. Kern, K. B., Hilwig, R. W., Rhee, K. H., & Berg, R. A. (1996). Myocardial dysfunction after resuscitation from cardiac arrest: An example of global myocardial stunning. Journal of the American College of Cardiology, 28, 232–240.

    Article  PubMed  CAS  Google Scholar 

  4. Klouche, K., Weil, M. H., Sun, S., Tang, W., Povoas, H. P., Kamohara, T., et al. (2002). Evolution of the stone heart after prolonged cardiac arrest. Chest, 122, 1006–1011.

    Article  PubMed  Google Scholar 

  5. DeAntonio, H. J., Kaul, S., & Lerman, B. B. (1990). Reversible myocardial depression in survivors of cardiac arrest. Pacing and Clinical Electrophysiology, 13, 982–985.

    Article  PubMed  CAS  Google Scholar 

  6. Zaugg, C. E., Ziegler, A., Lee, R. J., Barbosa, V., & Buser, P. T. (2002). Postresuscitation stunning: Postfibrillatory myocardial dysfunction caused by reduced myofilament Ca2+ responsiveness after ventricular fibrillation-induced myocyte Ca2+ overload. Journal of Cardiovascular Electrophysiology, 13, 1017–1024.

    Article  PubMed  Google Scholar 

  7. Hurst, T. M., Hinrichs, M., Breidenbach, C., Katz, N., & Waldecker, B. (1999). Detection of myocardial injury during transvenous implantation of automatic cardioverter-defibrillators. Journal of the American College of Cardiology, 34, 402–408.

    Article  PubMed  CAS  Google Scholar 

  8. Schlüter, T., Baum, H., Plewan, A., & Neumeier, D. (2001). Effects of implantable cardioverter Defibrillator implantation and shock application on biochemical markers of myocardial damage. Clinical Chemistry, 47, 459–463.

    PubMed  Google Scholar 

  9. Epstein, A. E., Kay, G. N., Plumb, V. J., Dailey, S. M., & Anderson, P. G. (1998). Gross and microscopic pathologic changes associated with nonthoracotomy implantable defibrillator leads. Circulation, 98, 1517–1524.

    PubMed  CAS  Google Scholar 

  10. Schirmer, U., Hemmer, W., Lindner, K. H., Anhaupl, T., & Wieser T. (1997). Ultrastructural alterations in the right and left ventricular myocardium following multiple low energy endocardial countershocks in anesthetized dogs. Pacing and Clinical Electrophysiology, 20, 79–87.

    Article  PubMed  CAS  Google Scholar 

  11. Steinbeck, G., Dorwarth, U., Mattke, S., Hoffmann, E., Markewitz, A., Kaulbach, H., et al. (1994). Hemodynamic deterioration during ICD implant: Predictors of high-risk patients. American Heart Journal, 127, 1064–1067.

    Article  PubMed  CAS  Google Scholar 

  12. Runsiö, M., Bergfeldt, L., Brodin, L. Å., Ribeiro, A., Samuelsson, S., & Rosenqvist, M. (1997). Left ventricular function after repeated episodes of ventricular fibrillation and defibrillation assessed by transoesophageal echocardiography. European Heart Journal, 18, 124–131.

    PubMed  Google Scholar 

  13. Poelaert, J., Jordaens, L., Visser, C. A., De Clerck, C., & Herregods, L. (1996). Transoesophageal echocardiographic evaluation of ventricular function during transvenous defibrillator implantation. Acta Anaesthesiologica Scandinavica, 40, 913–918.

    PubMed  CAS  Google Scholar 

  14. Robin, J., Weinberg, K., Tiongson, J., Carnethon, M., Reddy, M., Ciaccio, C., et al. (2006). Renal dialysis as a risk factor for appropriate therapies and mortality in implantable cardioverter-defibrillator recipients. Heart Rhythm, 3, 1196–1201.

    Article  PubMed  Google Scholar 

  15. Cuculich, P. S., Sánchez, J. M., Kerzner, R., Greenberg, S. L., Sengupta, J., Chen, J., et al. (2007). Poor prognosis for patients with chronic kidney disease despite ICD therapy for the primary prevention of sudden death. Pacing and Clinical Electrophysiology, 30, 207–213.

    Article  PubMed  Google Scholar 

  16. Turakhia, M. P., Varosy, P. D., Lee, K., Tseng, Z. H., Lee, R., Badhwar, N., et al. (2007). Impact of renal function on survival in patients with implantable cardioverter-defibrillators. Pacing and Clinical Electrophysiology, 30, 377–384.

    Article  PubMed  Google Scholar 

  17. Joki, N., Hase, H., Saijyo, T., Tanaka, Y., Takahashi, Y., Ishikawa, H., et al. (2003). Combined assessment of cardiac systolic dysfunction and coronary atherosclerosis used to predict future cardiac deaths after starting hemodialysis. American Journal of Nephrology, 23, 458–465.

    Article  PubMed  Google Scholar 

  18. Paoletti, E., Specchia, C., Di Maio, G., Bellino, D., Damasio, B., Cassottana, P., et al. (2004). The worsening of LVH is the strongest predictor of SCD in HD patients: A 10 year survey. Nephrology Dialysis Transplantation, 19, 1829–1834.

    Article  Google Scholar 

  19. Converse, R. L., Jacobsen, T. N., Toto, R. D., Jost, C. M., Cosentino, F., Fouad-Tarazi, F., et al. (1992). Sympathetic overactivity in patients with chronic renal failure. New England Journal of Medicine, 327, 1912–1918.

    Article  PubMed  Google Scholar 

  20. Aoki, J., Ikari, Y., Nakajima, H., Mori, M., Sugimoto, T., Hatori, M., et al. (2005). Clinical and pathologic characteristics of dilated cardiomyopathy in hemodialysis patients. Kidney International, 67, 333–340.

    Article  PubMed  Google Scholar 

  21. Landray, M. J., Wheeler, D. C., Lip, G. Y., Newman, D. J., Blann, A. D., McGlynn, F. J., et al. (2004). Inflammation, endothelial dysfunction, and platelet activation in patients with chronic kidney disease: The chronic renal impairment in Birmingham (CRIB) study. American Journal of Kidney Diseases, 43, 244–253.

    Article  PubMed  CAS  Google Scholar 

  22. Morales, M., Gremigni, C., Dattolo, P., Piacenti, M., Cerrai, T., Fazi, A., et al. (1998). Signal-averaged ECG abnormalities in haemodialysis patients. Nephrology Dialysis Transplantation, 13, 668–673.

    Article  CAS  Google Scholar 

  23. Covic, A., Diaconita, M., Gusbeth-Tatomir, P., Covic, M., Botezan, A., Ungureanu, G., et al. (2002). Haemodialysis increases QT(c) interval but not QT(c) dispersion in ESRD patients without manifest cardiac disease. Nephrology Dialysis Transplantation, 17, 2170–2177.

    Article  CAS  Google Scholar 

  24. Wong, C. K., Pun, K. K., Cheng, C. H., Lau, C. P., Leung, W. H., Chan, M. K., et al. (1990). Hypocalcemic heart failure in end-stage renal disease. American Journal of Nephrology, 10, 167–170.

    Article  PubMed  CAS  Google Scholar 

  25. Ghent, S., Judson, M. A., & Rosansky, S. J. (1994). Refractory hypotension associated with hypocalcemia and renal disease. American Journal of Kidney Diseases, 23, 430–432.

    PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. St. Mary’s/Duluth Clinic, 407 E 3rd St, Duluth, MN, 55805, USA

    Michael Mollerus & Leslee Naslund

Authors
  1. Michael Mollerus
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Leslee Naslund
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Michael Mollerus.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Mollerus, M., Naslund, L. Myocardial stunning following defibrillation threshold testing. J Interv Card Electrophysiol 19, 213–216 (2007). https://doi.org/10.1007/s10840-007-9150-9

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10840-007-9150-9

Keywords

Search

Navigation